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Diastolic dysfunction is a poorly understood but clinically pervasive syn-
drome. Titin is the main determinant of cellular passive stiffness. However,
the physiological role that titin’s tandem Ig segment plays in stiffness gener-
ation and whether shortening this segment is sufficient to cause diastolic
dysfunction needs to be established by performing studies at a wide range
of organizational levels (skinned cells to the in vivo LV chamber). We pro-
duced a novel KO model by deleting nine immunoglobulin(Ig)-like domains
from the proximal tandem Ig segment (Ig 3-11) of titin’s spring region (IG
KO). Exon microarray analysis revealed no adaptations in titin splicing, while
novel phospho-specific antibodies did not detect changes in titin phosphory-
lation. Passive myocyte stiffness was increased in the KO and immunoelec-
tron microscopy revealed increased extension of the remaining titin spring
segments as the likely underlying mechanism. Diastolic stiffness was
increased at the tissue and organ levels; myocardial stiffness studies did not
detect changes in extracellular matrix based passive stiffness, supporting
a titin-based mechanism. IG KO mice have a reduced exercise tolerance
and develop LV hypertrophy that is associated with a marked increase in ex-
pression of hypertrophy-associated four and a half LIM proteins (FHL). These
findings suggest that titin-based stiffness plays a role in diastolic dysfunction
and hypertrophic signaling and that increased titin-based passive stiffness is
sufficient to cause diastolic dysfunction with exercise intolerance and LV
hypertrophy.
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According to the Frank-Starling relationship, ventricular pressure increases
with end-diastolic volume. This is controlled, in large part, by sarcomere length
(SL) dependence of cardiac myofibrillar force, loaded shortening, and power.
Consistent with this, both myofibrillar force and power fall at shorter SL, how-
ever, when Ca2þ activated force and presumably thin filament activation levels
are matched between short and long SL (by increasing the activator [Ca2þ])
short SL actually yields faster loaded shortening and greater peak normalized
power output (PNPO). A potential mechanism for faster loaded shortening at
short SL is that as SL decreases titin becomes less taut which reduces the im-
pedance of cross-bridges, a process that may be mediated by titin’s interactions
with the thick filament. We propose a more slackened titin yields greater
myosin head radial and azimuthal mobility and these flexible cross-bridges
are more likely to maintain thin filament activation, which would allow more
force-generating cross-bridges to work against a fixed load resulting in faster
loaded shortening. We tested this idea by measuring SL dependence of power
at matched forces in rat skinned cardiac myocytes containing either N2B titin or
a longer, more compliant N2BA titin. We predicted less overshoot in power by
short SL in N2BA titin myocytes. Consistent with this, peak power did not
overshoot but was actually less at short versus long SL at matched thin filament
activation levels in N2BA-containing myocytes (Wt: DPNPO = þ0.0121 5
0.0115 (n=5), N2BA titin: DPNPO =0.05665 0.0493 (n=5)). These findings
are consistent with SL per se modulating the mechanical properties of cross-
bridges with this modulation being mediated by titin. This myofibrillar mech-
anism may help sustain ventricular power during periods of low preloads, and
perhaps a breakdown of this mechanism is involved in impaired function of
failing hearts.
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To understand the functional significance of phosphorylation that takes place in
the M domain of cMyBP-C, chemically skinned papillary muscle fibers of
transgenic mice were studied by sinusoidal length alterations and concomitant
tension transients. Muscle fibers were maximally activated at pCa 4.55 in thesolution that mimic physiological conditions (5 mM MgATP, 8 mM Pi,
200 mM total ionic strength with K-acetate) in myocytes. WT mice possess
phosphorylation sites S273, S282, and S302. SAS is a single mutant
S282A, and ADA and DAD are triple mutants S273A/S282D/S302A and
S273D/S282A/S302D, respectively. D models for phosphorylation (phospho-
mimetic), and A models for non-phosphorylation (phosphor-ablation). Isomet-
ric tension and stiffness of DAD were respectively ~0.5x of those of WT, but
tension and stiffness of t/t (cMyBP-C null), ADA, and SAS were respectively
similar to WT. The fast rate constant 2pc of DAD and t/t was ~0.6x of WT,
but that of ADA and SAS was similar to WT. The intermediate rate constant
2pb of DAD and SAS was ~1.3x of WT, but that of ADA and t/t was
similar to WT. These results demonstrate that cMyBP-C M domain phosphor-
ylation affects the cross-bridge kinetics at ATP binding and phosphate
release steps, indicating that phosphorylation affects myosin structure and
its interaction with actin. However, pCa-tension and pCa-stiffness studies
demonstrated that pCa50 (Ca
2þ sensitivity) and nH (cooperativity) were
respectively not different among mutants and WT groups, indicating that
phosphorylation of cMyBP-C has a minimal effect on the regulatory system.
The decreased amount of isometric tension only in DAD indicates that phos-
phorylation of S273 and S302 are most significant and they diminish the force
generation capability, presumably owing to the extra electrostatic interaction of
the M domain of cMyBP-C with actin thin filament, which may serve as
a break.
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Cardiac myosin binding protein-C (cMyBP-C) modulates contractility in part
through phosphorylation of serines (S) found in the cardiac-specific motif be-
tween domains C1 and C2. S282 phosphorylation appears to allow the hierar-
chical phosphorylation of S302 and S307 by protein kinase-A (PKA). We
investigated whether S282 phosphorylation status influenced the effects of
PKA on acto-myosin cross-bridge MgADP release rate (k-ADP) and MgATP
binding rate (kþATP) in myocardial strips. Transgenic mice expressing
cMyBP-C with a single amino acid switch at S282 to glutamic acid (D) or al-
anine (A) were generated to mimic phosphorylated or unphosphorylated states,
respectively. Mice were fed L-thyroxin for 10 days to ensure similar (>90%)
a-myosin heavy chain (a-MyHC) background. Skinned papillary muscles
were pretreated with alkaline phosphatase to reduce any differential in vivo
phosphorylation, and examined by length perturbation analysis at maximum
calcium activation (pCa 4.8) as MgATP concentration varied (0 to 5 mM).
a-MyHC k-ADP and kþADP increased 90% (212522 vs. 11159 s
1) and 45%
(867593 vs. 595550 mM1 s1) for S282D vs. S282A, demonstrating that
cMyBP-C S282 phosphorylation status significantly affects a-MyHC kinetics.
Following PKA treatment, k-ADP and kþADP values did not differ between
S282D and S282A, due to PKA reducing k-ADP by 23% (163519 s
1) and
kþATP by 45% (475535 mM
1 s1) for S282D, but increasing k-ADP by 23%
(13759 s1) and decreasing kþATP by 23% (457552 mM
1 s1) for S282A.
These results suggest that S282 phosphorylation most significantly affects
the initial functional status of the myocardium, prior to PKA-mediated effects
from cMyBP-C or other phosphorylatable myofilament proteins.
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Myosin binding protein-C (MyBPC) has been known for over thirty years to
inhibit actomyosin ATP hydrolysis and more recently has been shown to affect
the calcium sensitivity of force in muscle fibers. The various domains of
MyBPC have previously been shown to have complex interactions with other
myofibrillar proteins. The C-terminal domains have been shown to bind to
the thick filament and the N-terminal domains interact with the S2 region of
myosin and with f-actin. The number of mutations in cardiac MyBPC
(cMyBPC) are the second most prevalent of sarcomeric proteins in producing
cardiomyopathies. We have used steady state kinetics to study the molecular
mechanism by which the soluble N-terminal C0C1, C1C2 and C0C2 domains
of mouse and human cMyBPC affect the activation of myosin ATP hydrolysis
by f-actin and native porcine thin filaments.
